Company's expanded portfolio now includes rigid and soft touch plastics
Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, will introduce its portfolio of thermoplastic elastomers (TPEs) for medical devices at two major industry shows: MD&M West in Anaheim, Calif. from February 5-7 at Booth 1986 and Pharmapack EU in Paris from February 6-7 at Booth D94. This portfolio of TPEs complements Trinseo's traditional rigid plastics offering, making Trinseo a one-stop-shop for both hard and soft plastics.
Trinseo has supported the medical devices market for nearly three decades and is known for superior product quality, outstanding consistency, and a focus on customer compliancy requirements. The expanded portfolio enhances Trinseo's offering with soft touch materials and overlays that are often needed with hard plastics.
TPEs can serve as a vinyl substitute. With their elastomeric composition, TPEs can allow better handling of medical devices and potentially increase performance, functionality, usability, and aesthetics, while helping to improve patient care and contribute to patient safety.
"We've brought together a very high quality portfolio of rigid plastics with TPEs that have been specifically formulated for the medical devices sector," said Aldo Zanetti, business unit manager TPE Solutions Medical Packaging for Trinseo. "This move helps us meet the needs of medical customers, particularly as the industry addresses trends in health care that require medical devices and equipment that are more patient friendly and service provider friendly."
Trinseo offers two styrenic block copolymers (TPSs) to the medical devices industry under the brands MEGOL and RAPLAN. Materials are biocompatibility tested and available with full biocompatibility (MED) and limited testing approved for skin contact (SK), providing customers with the most economical material option, since not all medical devices require full biocompatibility.
Trinseo's rigid plastics for medical devices include:
- CALIBRE Polycarbonate (PC) for fluid and drug delivery via syringes, stopcocks and luers.
- CALIBRE (Glass-filled) PC-GF for handles and housings of surgical devices.
- EMERGE PC/ABS and PC/PET for housings and covers of monitoring devices.
- MAGNUM ABS for portable device housings i.e. diabetes management equipment, glucose meters, pumps and insulin pens.
Trinseo supports medical devices customers with material solutions for Single and Multiple Use Devices, Equipment Housings, Drug Delivery Systems, and Medical Wearables. As the medical industry continues to evolve and bring life-enhancing devices to market, global medical device and pharmaceutical manufacturers rely on Trinseo to respond with materials developed to meet their needs. The company adheres to current Good Manufacturing Practices (cGMP) and holds an ISO 13485 certification.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day products that are intrinsic to how we live our lives across a wide range of end-markets, including automotive, consumer electronics, appliances, medical devices, lighting, electrical, carpet, paper and board, building and construction, and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com.
Note on Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Tel: +1 248 802 2783
Tel: +49 221 93322-247